Cover Image SWEDISH ORPHAN BIOVITRUM AB (SOBI)
SWEDISH ORPHAN BIOVITRUM AB (SOBI)

SWEDISH ORPHAN BIOVITRUM AB (SOBI)

Summary


Swedish Orphan Biovitrum (SOBI) operates as a bio-pharmaceutical and bio-technology company. The Company develops therapies and drugs for the treatment of haemophilia, inflammation, and genetic diseases. SOBI serves clients worldwide.

Deals Overview

Total Deals4
Valued Deals4
Total Value£8,310M
Avg. Deal Size£2,077M

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US